The invention relates to substituted N-Aliphatic-N-Aromatic tertiary-Heteroalkylamine compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions and methods for treating atherosclerosis, dyslipidemia, and other coronary artery disease.
该发明涉及取代的N-脂肪基-N-芳香族三元杂基胺化合物,可用作
胆固醇酯转移蛋白(CETP;血浆脂质转移蛋白-I)的
抑制剂,以及用于治疗动脉粥样硬化,血脂异常和其他冠状动脉疾病的化合物,组合物和方法。